baber/WOPTO huggingface dataset:
Patent FI-101791-B1 (FI)
Inventor: COSSEMENT ERIC
IPC: C07D233/64
Filed: 1989-04-26
Granted: 1998-08-31
Abstract: New substituted 1-(1H-imidazol-4-yl)alkyl-benzamides and their salts, processes for the preparation thereof and pharmaceutical compositions. These compounds have the formula  <IMAGE>  wherein R1, R2=hydrogen or C1-C4-alkyl, R3=hydrogen, amino, hydroxyl, C1-C4-alkyl or C1-C4-hydroxyalkyl, R4=hydrogen or C1-C4-alkyl, or R3R4N=pyrrolidino, piperidino or morpholino, R5 and R6=hydrogen, hydroxyl, C1-C4-alkyl or C1-C4-alkoxy, at least one of R5 and R6 being other than hydrogen. These compounds are prepared either by reacting a nitrogen compound with an alkyl 1-(1H-imidazol-4-yl)alkyl-benzoate or with a 1-(1H-imidazol-4-yl)alkyl-benzoic acid, or by hydrolyzing in an acid medium a 2-hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzonitrile. The compounds have anti-ischemic and  alpha 2-adrenoceptor agonist activities.
Patent IE-63672-B1 (IE)
Title: Novel 2beta-morpholino-androstane derivatives and processes for their preparation
Inventor: SLEIGH THOMAS
IPC: C07J1/00
Filed: 1988-04-06
Abstract: 2-Morpholinyl-androstane derivs. of fomrula (I), their mono- and bis-quat. ammonium cpds. and the acid addn. salts of (I) or its mono-quat. ammonium cpds. are new. In the formula, R1 = H or 1-12C opt. substd. acyl; R2 = H or 1-12C acyl; R3 = CH2, N(Me) or a bond. - Pref. R1 = H; R2 = 1-6C satd. acyl; R3 = CH2 or bond; and cpds. are 16 beta-monoquat. ammonium cpds..
Patent IE-74127-B1 (IE)
Title: Device for iontophoretic drug delivery
Inventor: PHIPPS JOSEPH BRADLEY
IPC: A61K9/00
Filed: 1991-03-28
Abstract: An iontophoretic device having a two-layer active electrode element is disclosed. The active element is composed of overlapping skin contact hydrogel and carrier layers. The carrier layer contains dispersed or dissolved active agent. The active electrode element maintains the active agent in stable form and permits efficient transport of the active agent to the host. Also disclosed is an iontophoretic device having a single layer active electrode element. The single layer is a hydrogel as manufactured or substantially dry and capable of being hydrated before use. The skin contact hydrogel of the two-layer active electrode element preferably.
Patent IE-34533-B1 (IE)
Title: Improved anaerobic polymerisable composition
IPC: C08F2/02
Filed: 1970-09-17
Abstract: 1281776 Laminates LOCTITE CORP 1 Oct 1970 [2 Oct 1969] 46698/70 Heading B5N [Also in Division C3] Glass or plastics surfaces, e.g. polystyrene, polyvinyl chloride, acrylonitrile/butadiene/styrene copolymer and poly (hexamethylene adipamide) are bonded together with anaerobically polymerizable adhesives comprising an ester of acrylic or α-substituted acrylic acid and a polymerization initiator system comprising (i) a hydroperoxide (or a peroxide that decomposes to form a hydroperoxide in situ) and (ii) an organic peroxide other than a hydroperoxide. The adhesives may also include accelerators such as benzoic sulphimide, N,N- diethyl-p-toluidine and inhibitors such as pbenzoquinone.
[GB1281776A]
Patent IE-65408-B1 (IE)
Title: Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
Inventor: FLESHER ALAN RAY
IPC: C12N15/02
Filed: 1988-04-29
Abstract: Monoclonal antibodies capable of binding antigenic determinants within region of the core proteins of the Human Immunodeficiency Virus and immortalized cell lines producing those monoclonal antibodies are provided. The monoclonal antibodies find use in a variety of ways, including HIV antigen detection in biological samples. Using these methods, individuals may be identified who are infected with HIV but who have not yet developed anti-HIV antibodies. The methods also find use in monitoring in vitro growth of HIV, and the efficacy of therapeutic agents and vaccines.
Patent IE-62888-B1 (IE)
Title: alfa-substituted 4-(quinolin-2-yl-methoxy) phenylacetic acids and esters
Inventor: MOHRS KLAUS
IPC: C07D215/14
Filed: 1989-04-28
Abstract: alpha -Substituted 4-(quinolin-2-ylmethoxy)phenylacetic acids and esters can be prepared by reaction of appropriate phenols with 2-halomethylquinolines or by reaction of appropriately substituted quinoline with halides. The novel compounds can be employed as active substances in medicaments.
Patent IE-41891-B1 (IE)
Title: A process and installation for pelletizing organic waste materials
IPC: F26B1/00
Filed: 1975-06-30
Abstract: 1495772 Processing organic waste SAF SOC AGRICOLE ET FONCIERE SA 20 May 1975 [3 July 1974 13 Nov 1974] 21369/75 Heading B5A [Also in Division B2] A system for pelletizing organic waste materials for fertilizers comprises areas for storing 1 and mixing 4 organic waste materials, a chamber for passing hot, dust-carrying exhaust gas through mixer to partly dried organic waste material to recuperate the heat in the gas and the dust carried thereby, an oven 6 Fig. 1, for heating mixed organic materials, means to break and pulverize the mixed and partly dried organic materials, an adjustable supply means 15 ... 17, Fig. 3, chopping means 18 receiving organic materials from the supply means, means 20 to extrude the chopped organic materials to form strands, at least one perforated vibratory plate 22 receiving broken stands from the extruder 20, means to supply a rising current of hot air through perforations of the plate and at least one silo (not shown) for the product. As described wet material is stored at 1, liquid manure at 2, dry material at 3 and the wet and dry materials are mixed by a mechanical shovel at 4. Dry material and liquid manure are mixed at 5. Predrying is effected in the oven 6. Metal is removed at 9 and clods are crushed at 10, by rodes having helicoidal ribs, followed by rolling at 12, Fig. 2, the material being stored at 14 with a water content of 50 to 55%. This starting material is chopped by a chopper 18 which includes knives before and after the extruding plate 27, and the stands are further reduce by an extruder 20 which has no cutters. Evaporation of moisture takes place in the vibratory fluidized bed 22. Exhaust gases collected in a chimney 33 are returned to an expansion chamber 7, Fig. 1, which may include a heated belt conveyer or a fixed grid. Further evaporating beds may be used for large scale production, viz. 37 and 41 Fig. 4. The product from bed 41 can be stored in silos.
Patent IE-45861-B1 (IE)
Title: Hydrometallurgical recovery of lead from mixed metal sulphides
IPC: C22B3/00
Filed: 1977-07-20
Abstract: The specification describes a hydrometallurgical process for treating a mixture of metal sulphides containing lead sulphide, wherein the sulphide mixture is treated with an aqueous lixiviating solution containing at least one chloride selected from the chlorides of copper, bismuth, antimony, arsenic and silver, the quantity of the said chlorides used being not more than 120% of that which is stoichiometrically required for the complete dissolution of the lead contained in the sulphides.
Patent IE-39007-B1 (IE)
Title: Apparatus for displaying materials and combinations of materials
IPC: G09F1/10
Filed: 1973-09-11
Abstract: An apparatus for displaying materials and combinations of materials including a main rail and a plurality of side rails positioned serially one after each other. At least one side of each side rail is connected to the main rail by a switch. A plurality of panels on which the materials to be displayed are mounted are connected to the main and side rails by moving means such as guide rollers so that the panels can be moved along the rails. Each of the moving means includes a vertical shaft on which one of the panels is mounted with the panels being freely rotatable about the vertical shaft. The side rails are spaced apart from each other a distance greater than or at least substantially equal to the width of the panels.
[US3984930A]
Patent IE-51536-B1 (IE)
Title: Process for preparing 3-chloro-6-(2-hydroxyphenyl)pyridazines
IPC: C07D237/12
Filed: 1981-09-01
Abstract: A process for preparing 3-chloro-6-(2-hydroxyphenyl)-pyridazines by the reaction of 6-(2-hydroxyphenyl)-3(2H)-pyridazinones with phosphorus oxychloride and a disubstituted formamide. The chloropyridazine compounds are useful intermediates for preparing compounds which have β-adrenergic blocking and vasodilator activity and are useful as antihypertensive agents:
Patent IE-45622-B1 (IE)
Title: Cutting sheets
IPC: C03B33/037
Filed: 1977-10-11
Abstract: A form-cutting machine is disclosed for cutting a form in a flat surface of a sheet of material such as glass in response to a numerical control signal, the shape of the form being determined by the numerical control signal. The form-cutting machine comprises a frame, sheet-support means for supporting the sheet of material to be cut, an X-direction carriage-positioning assembly, a Y-direction carriage-positioning assembly, and a tool carriage having a cutting tool mounted on it so that the cutting tool can be positioned in a plane in which the cut is to be made. Each carriage-positioning assembly includes a carriage support member which extends generally perpendicular to a direction of motion, two guide members fixed to the frame which are spaced apart from one another and extend generally parallel to the direction of motion, and two sliders connected to ends of the carriage support member and slideably mounted on the two guide members. Each carriage-positioning assembly also includes a drive motor fixedly secured to the frame for moving the carriage-support member and toothed-belt means for connecting the drive motor and the carriage support member so that motion produced by a motor is imparted to the support member with substantially no slippage. The tool carriage is slideably mounted on the two substantially perpendicular carriage-support members, so that moving the carriage support members causes the cutting tool to move in a plane. The form-cutting machine further comprises circuit means connected to the drive motors so that the carriage support members and, consequently the tool carriage, are positioned in response to the numerical control signal.
Patent IE-41765-B1 (IE)
Title: A method of preventing or controlling parasitic infestation of livestock
IPC: A61K31/425
Filed: 1974-10-30
Abstract: 1530161 Anthelmintics AN FORAS TALUNTALS 30 Oct 1975 [30 Oct 1974] 44950/75 Heading A5B Parasitic infestation of livestock e.g. sheep, cattle, goats, pigs and horses is prevented or controlled by putting the animals on pasture at the beginning of the grazing season when the pasture is relatively free of helminth parasitic infection, and administering an anthelmintic to the livestock through their drinking water on a continual daily basis throughout a substantial part or all of the grazing season so as to suppress helminth egg or larval output from the animals such that heavy helminth contamination of the pasture is prevented. The anthelmintic is preferably morantel tartrate, levamisole and/or diethylcarbamazine citrate.
Patent IE-62032-B1 (IE)
Title: Cosmetic or pharmaceutical composition containing microspheres of polymers or fatty substances filled with at least one active product
Inventor: SCHAEFER HANS
IPC: A61K9/16
Filed: 1989-12-19
Abstract: The invention relates to a pharmaceutical or cosmetic composition for topical application, containing, in a suitable carrier, microspheres of polymers or of fatty substances filled with at least one active product, characterized in that at least 80% of the microspheres employed have a diameter of between 3 (my)m and 10 (my)m.
Patent IE-67321-B1 (IE)
Title: 14alpha, 17alpha-ethano-16alpha-hydroxy-estratrienes
Inventor: KIRSCH GERALD DR
IPC: C07J53/00
Filed: 1990-11-29
Abstract: New 14alpha, 17alpha-bridged oestratrienes of formula (I) are claimed. When OR3 is in the alpha-configuration: R1, R2, R3 = H, -CO-R4 or -(CH2)n-CO2H, where n = 1-4. R1 may also be benzyl, 1-8C alkyl or 3-5C cycloalkyl; R4 = an organic gp. with up to 11C atoms. When OR3 is in the beta-configuration: R1, R2, R3 = H or 1-12C acyl; R1 may also be 1-8C alkyl. In both cases, A-B is an etheno or etheno bridging bond. 18 cpds. are specifically claimed, including 3-benzyloxy-14alpha, 17alpha-ethano- 1, 3, 5(10)oestratriene-16alpha, 17beta-diol and 14alpha, 17alpha-ethano -1, 3, 5(10) oestratriene-3, 16alpha, 17beta-triol. Also claimed is a method of preparing (I), e.g. from 3, 16beta, 17beta-triacetoxy-14alpha, 17alpha-ethano-1, 3, 5 (10)-oestratriene-16alpha-carbonitrile. For treating disorders involving oestrogen deficiency, unit oral dose is 0.001-0.05 mg. Solns. for intramuscular injection contain 0.01-1 mg (I) per ml, and vaginal salves contain 0.1-10 mg (I) per 100 ml. For contraception, tablets contain 0.003-0.05 mg (I) and 0.05-0.5 mg of a gestagen.
Patent LU-500364-B1 (LU)
Title: Pixel configuration in light emitting modules
Inventor: WILLEM PATRICK
IPC: G09F9/33
Filed: 2021-06-30
Granted: 2023-01-02
Abstract: The invention relates to an arrangement of light emitting elements for a light emitting module, wherein the light emitting elements are configured in a hexagonal arrangement such that a light emitting element is provided in the center of each hexagon and, each light emitting element is centered on an edge of a hexagon, such that the light emitting elements are arranged along a first, a second and a third row, wherein the light emitting elements have an elongated shape, such äs a rectangle, having a length greater than or equal to a width, the orientation of the length defining the orientation of the light emitting element, and wherein each pair of two adjacent light emitting elements have a different orientation, or wherein, the light emitting elements have at least one of a hexagonal or a circular shape.
Patent NO-300993-B1 (NO)
Inventor: BRAUKER JAMES H
IPC: A61K9/22
Filed: 1992-06-29
Abstract: A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.
Patent NO-300690-B1 (NO)
Inventor: BAUDY REINHARDT BERNHARD
IPC: A61K31/675
Filed: 1992-10-09
Abstract: The compounds of the formula <CHEM>  wherein     R is hydrogen, lower alkyl, benzyl or pivaloyloxymethyl; R<1> and R<2> are, independently, hydrogen, lower alkyl, lower alkoxy, trifluoromethyl, trifluoromethoxy, methanesulfonylamino, acetylamino, or halo, or when taken together R<1> and R<2> represent a methylenedioxy grouping; and the pharmacologically acceptable salts thereof are NMDA antagonists useful in the treatment and prevention of central nervous system related pathological conditions resulting from overstimulation by excitatory amino acids. Processes for preparing the compounds and pharmaceutical compositions containing them are also covered.
Patent NO-301106-B1 (NO)
Inventor: EASTMAN ALAN DAN
IPC: C07C9/16
Filed: 1993-09-30
Abstract: Described is a novel process for regenerating an ASO contaminated alkylation catalyst which contains a sulfone component and a hydrogen halide component. The alkylation catalyst undergoes a series of separation steps to remove a significant portion of the hydrogen halide component contained therein followed by a phase separation between an ASO phase and a sulfone phase. The sulfone phase is then contacted with a carbon material to remove a portion of any remaining ASO contained in the sulfone. <IMAGE>
Patent NO-308976-B1 (NO)
Title: Skifting av fase ved et klokkesignal
Inventor: HEDBERG MATS
IPC: H03K5/13
Filed: 1994-06-10
Abstract: Søknaden vedrører klokkegjenvinning for et digitalt datasignal. En fasedetektor (2) mottar datasignalet og sender det ut etter klokkegjenvinning. Et fasekorrigerende middel (8) tilveiebringer og sender ut, ved hjelp av et antall hjelpeklokkesignaler fasefor-skjøvet i forhold til hver andre og stammende fra et innkommende klokkesignal (CK), et gjenvunnet klokkesignal (CK) for datasignalet. Det gjenvunne klokkesignal mates til fasedetektoren (2), som detekterer en eventuell faseposisjonsfeil mellom datasignalet og dets gjenvunne klokkesignal og avgir informasjon vedrørende dette til fasekorrigerende middel (8). De fasekorrigerende middel (8) omfatter en fasevariasjonskrets (16) innrettet til, hvis faseposisjonsfeilen avviker fra null og faseposisjonen til det gjenvunne klokkesignal er plassert mellom faseposisjonene til to av hjelpeklokkesignalene, å blande disse to hjelpeklokkesignaler med hverandre for å danne et justert gjenvunnet klokkesignal med samme faseposisjon som datasignalet. Oppfinnelsen tillater forskyvning av fasen til et klokkesignal kontinuerlig et antall tørn fremover eller bakover uten avbrudd eller diskontinuiteter i det gjenvunne klokkesignal. Dette medfører at oppfinnelsen også kan brukes i tilfelle det oppstår en forskjell mellom bitfrekvensen av innkommende data og klokkereferansefrekvensen.
Patent NO-320170-B1 (NO)
Inventor: JOHANSEN NIELS
IPC: G01N33/53
Filed: 1995-05-11
Abstract: A method of detecting an antibody in a sample using a labelling compound and comprising the steps of mixing a ligand antigen, antibody or hapten bound to biotin with the sample; an antibody directed against the antibody to be detected bound to paramagnetic particles; and a chemiluminescent acridinium compound bound to avidin or streptavidin to form a solid phase complex; separating the solid phase from the liquid phase; and analysing the separated solid phase for the presence of chemiluminescent complex.
Patent NO-301182-B1 (NO)
Inventor: HOLLSTEDT PER
IPC: E04H6/12
Filed: 1995-09-01
Abstract: PCT No. PCT/NO96/00214 Sec. 371 Date Jun. 4, 1998 Sec. 102(e) Date Jun. 4, 1998 PCT Filed Aug. 30, 1996 PCT Pub. No. WO97/09498 PCT Pub. Date Mar. 13, 1997A house for parking bicycles so that bicycles can be placed separately in a circular storage area. The bicycles are positioned radially with the rear ends of the bicycles being directed toward the center axis of the house. The storage area of the house is provided with fixed walls and a door thus providing a closed room with at least one door. The floor of the area is sloped toward the center axis and is shaped as a double floor of which the inner floor is rotatable. The storage area is divided into stalls for placing the bicycle.
Patent NO-320674-B1 (NO)
Inventor: MONCRIEF FRANK
IPC: B31B50/76
Filed: 1996-12-20
Abstract: A hold-down element for a rotary feeder has a curved elongated member for continuously contacting an article during rotation of a rotary head. The curvature of the hold-down element is selected so that the distance from the elongated member to the rotary head increases from the point of initial contact to the final contact point on the elongated member. The hold-down element preferably maintains contact for at least 20 DEG  of rotation of the rotary head, and thus maintains contact with the article for an extended period of time. The hold-down element is attached to a vacuum shaft on the rotary head, and is prevented from rotating relative to the vacuum shaft by a keyway on the hold-down element and a key on the vacuum shaft. The hold-down element, however, is permitted to travel transversely along a longitudinal axis of the vacuum shaft in order to accommodate different shaped articles.
Patent NO-317155-B1 (NO)
Inventor: TANI KOUSUKE
IPC: C07C405/00
Filed: 1998-02-02
Abstract: omega -Cycloalkyl-prostaglandin E2 derivatives of formula (I) <CHEM> wherein R is carboxy or hydroxymethyl; R<1> is oxo, methylene or halogen atom; R<2> is H, OH or C1-4 alkoxy; R<3> is H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C1-8 alkyl, C2-8 alkenyl or C2-8 alkynyl substituted by 1-3 substituents selected from halogen atom, C1-4 alkoxy, C3-7 cycloalkyl, phenyl, and phenyl substituted by 1-3 substituents selected from halogen atom, C1-4 alkyl, C1-4 alkoxy, nitro and trifluoromethyl; n is 0-4; and non-toxic salts thereof, prodrugs thereof and cyclodextrin clathrates thereof strongly bind on the EP2 subtype receptor. Therefore, they are useful for prevention and/or treatment of immunological diseases (autoimmune diseases, organ transplantation, etc.), asthma, abnormal bone formation, neuronal cell death, liver damage, abortion, premature birth or retina neuropathy of glaucoma etc.
Patent NO-316100-B1 (NO)
Inventor: RANTANEN KARI
IPC: H04L29/06
Filed: 1998-08-18
Abstract: Disclosed is a system and method to transmit data to a company's data system by a mobile phone connected to a mobile communications network, and receive an acknowledgment to the same mobile phone from the company's data system. A preset target number dialed by a mobile phone is directed to an intelligent network center. The target number is decoded into data which is transmitted to a company's data system during the connection. The intelligent network center uses the caller's identifying number to check whether the caller is entitled to use the service, and to check to which information system of which company the data has been sent. The intelligent network center transmits a telecommunications network signaling the target number, caller's number and address of the company's to a voice server computer capable of identifying telephone numbers and formulate voice messages. The voice server converts the target number into data and transmits the data and the caller's number to the company's data system using a data network protocol. The company's data system stores the data in the data system and formulates a return message, which includes an acknowledgment of the received data and further a possible additional information, and transmits it to the voice server using the data network. The voice server transmits using the mobile communications network the return message either as a GSM short message or as a voice message to the mobile station which transmitted the data code, or as a pager message to a desired pager device.
Patent NO-321392-B1 (NO)
Inventor: MARTINENGO ANTONIO
IPC: H01F27/28
Filed: 1999-08-12
Abstract: A transposed cable (1) is disclosed comprising a core (2) consisting of a plurality of flattened wires (3) disposed in mutually superposed relationship to form two stacks (4a, 4b) arranged parallelly and side by side, the flattened wires (3) located at the base and on top of said stacks (4a, 4b) being cyclically transposed from one stack to the other. One or more thread-like elements (6a, 6b) of polyester or any other appropriate material are helically wound around the core (2), optionally in opposite winding directions. At least one ribbon-like element (7) of paper or other material is wound over the thread-like elements (6a, 6b) and superposed thereon, said ribbon-like element being tearable by means of a tear thread (8) longitudinally interposed between the paper ribbon (7) and the thread-like elements (6a, 6b) wound over the core (2). The tear thread (8) is used to remove the paper ribbon (7) when the cable (1) is wound around a winding core (23) to make an electric winding. <IMAGE>
Patent RO-112697-B1 (RO)
Inventor: NANI M VIOREL MIHAI
IPC: B21D22/02
Filed: 1992-06-29
Abstract: Invenţia se referă la un dispozitiv de crestare a tablelor ondulate utilizate ca elemente de omogenizare a substanţelor vâscoase din industria chimică. Problema tehnică pe care o rezolvă invenţia este de a realiza un dispozitiv de crestare a tablelor ondulate, care să asigure crestarea, prin ştanţarea (şliţuire) unor porţiuni dintr-un semifabricat sub forma unei table ondulate sau în zig-zag, urmată de îndoirea diametral opusă a acelei porţiuni, prin deformare plastică. Dispozitivul conform invenţiei este alcătuit, în principal, dintr-o matriţă (4) care are o formă profilată, corespunzătoare profilului semifabricatului în care se practică o cavitate identică cu forma finală a crestăturii. Matriţa (4) este poziţionată sub un anumit unghi (alpha) faţă de direcţia de deplasare a unui poanson prismatic, care are partea activă identică cu forma finală a crestăturii şi a cavităţii din matriţă, şi faţă de care se poate deplasa relativ un tampon (19) având la rândul său un profil înclinat, conjugat faţă de matriţă,